Pamela Villalobos

5.5k total citations
27 papers, 1.3k citations indexed

About

Pamela Villalobos is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Pamela Villalobos has authored 27 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Pamela Villalobos's work include Cancer Immunotherapy and Biomarkers (7 papers), Microtubule and mitosis dynamics (5 papers) and Cancer Cells and Metastasis (4 papers). Pamela Villalobos is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Microtubule and mitosis dynamics (5 papers) and Cancer Cells and Metastasis (4 papers). Pamela Villalobos collaborates with scholars based in United States, Australia and Chile. Pamela Villalobos's co-authors include Ignacio I. Wistuba, Jaime Rodriguez‐Canales, Barbara Mino, Edwin R. Parra, Carmen Behrens, Jaime Rodriguez Canales, Chad J. Creighton, Don L. Gibbons, Pan Tong and David H. Peng and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Pamela Villalobos

24 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pamela Villalobos United States	18	621	598	350	329	161	27	1.3k
Karsten Gravdal Norway	16	465 0.7×	620 1.0×	354 1.0×	330 1.0×	133 0.8×	28	1.2k
Andrea Malfettone Spain	23	664 1.1×	705 1.2×	321 0.9×	358 1.1×	206 1.3×	53	1.5k
David Balli United States	16	826 1.3×	764 1.3×	464 1.3×	360 1.1×	264 1.6×	31	1.6k
Chee Wee Ong Singapore	21	688 1.1×	845 1.4×	314 0.9×	338 1.0×	179 1.1×	35	1.5k
Véronique Ouellet Canada	22	493 0.8×	770 1.3×	205 0.6×	314 1.0×	208 1.3×	47	1.4k
Mariam Jamal‐Hanjani United Kingdom	18	488 0.8×	447 0.7×	386 1.1×	424 1.3×	158 1.0×	42	1.1k
Marianna Gallo Italy	18	693 1.1×	588 1.0×	328 0.9×	319 1.0×	123 0.8×	37	1.3k
Naohiro Uraoka Japan	18	484 0.8×	602 1.0×	210 0.6×	330 1.0×	149 0.9×	48	1.1k
Isa Mambetsariev United States	17	370 0.6×	467 0.8×	470 1.3×	269 0.8×	87 0.5×	70	1.1k
Min Hye Jang South Korea	20	1.0k 1.7×	610 1.0×	279 0.8×	473 1.4×	303 1.9×	42	1.7k

Countries citing papers authored by Pamela Villalobos

Since Specialization

Citations

This map shows the geographic impact of Pamela Villalobos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pamela Villalobos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pamela Villalobos more than expected).

Fields of papers citing papers by Pamela Villalobos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pamela Villalobos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pamela Villalobos. The network helps show where Pamela Villalobos may publish in the future.

Co-authorship network of co-authors of Pamela Villalobos

This figure shows the co-authorship network connecting the top 25 collaborators of Pamela Villalobos. A scholar is included among the top collaborators of Pamela Villalobos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pamela Villalobos. Pamela Villalobos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Villalobos, Pamela, et al.. (2021). Giant Cell Tumor of the Temporal Bone With Skull Base and Middle Ear Extension. Journal of Medical Cases. 12(4). 149–151. 4 indexed citations

Hight, Suzie K., Rahul K. Kollipara, Elizabeth A. McMillan, et al.. (2020). An in vivo functional genomics screen of nuclear receptors and their co-regulators identifies FOXA1 as an essential gene in lung tumorigenesis. Neoplasia. 22(8). 294–310. 25 indexed citations

Zheng, Lin, Zibo Chen, Masanori Kawakami, et al.. (2019). Tyrosine Threonine Kinase Inhibition Eliminates Lung Cancers by Augmenting Apoptosis and Polyploidy. Molecular Cancer Therapeutics. 18(10). 1775–1786. 27 indexed citations

Villalobos, Pamela, et al.. (2019). Salivary Duct Carcinoma of the Submandibular Gland: A Case Report and Review of the Literature. Journal of Medical Cases. 10(12). 354–358.

Yu‐Lee, Li‐Yuan, Guoyu Yu, Yu‐Chen Lee, et al.. (2018). Osteoblast-Secreted Factors Mediate Dormancy of Metastatic Prostate Cancer in the Bone via Activation of the TGFβRIII–p38MAPK–pS249/T252RB Pathway. Cancer Research. 78(11). 2911–2924. 126 indexed citations

Oswald, Nathaniel W., Elizabeth A. McMillan, Kathleen McGlynn, et al.. (2018). HORMAD1 Is a Negative Prognostic Indicator in Lung Adenocarcinoma and Specifies Resistance to Oxidative and Genotoxic Stress. Cancer Research. 78(21). 6196–6208. 47 indexed citations

Parra, Edwin R., Pamela Villalobos, Jiexin Zhang, et al.. (2018). Immunohistochemical and Image Analysis-Based Study Shows That Several Immune Checkpoints are Co-expressed in Non–Small Cell Lung Carcinoma Tumors. Journal of Thoracic Oncology. 13(6). 779–791. 50 indexed citations

Tang, Chad, Brian P. Hobbs, Ahmed M. Amer, et al.. (2018). Development of an Immune-Pathology Informed Radiomics Model for Non-Small Cell Lung Cancer. Scientific Reports. 8(1). 1922–1922. 113 indexed citations

Silva, Angelica M., Pamela Villalobos, Michelle D. Williams, et al.. (2018). Characterizing parathyroid carcinomas and atypical neoplasms based on the expression of programmed death-ligand 1 expression and the presence of tumor-infiltrating lymphocytes and macrophages. Surgery. 164(5). 960–964. 13 indexed citations

10.

Mustachio, Lisa Maria, Yun Lu, Laura J. Tafe, et al.. (2017). Deubiquitinase USP18 Loss Mislocalizes and Destabilizes KRAS in Lung Cancer. Molecular Cancer Research. 15(7). 905–914. 34 indexed citations

11.

Behrens, Carmen, Edwin R. Parra, Jaime Rodriguez‐Canales, et al.. (2017). OA19.02 Sex Differences Are Detected in the Profile of Tumor Associated Inflammatory Cells (TAICs) Are Lung Adenocarcinoma. Journal of Thoracic Oncology. 12(1). S318–S318.

12.

Parra, Edwin R., Pamela Villalobos, Barbara Mino, & Jaime Rodriguez‐Canales. (2017). Comparison of Different Antibody Clones for Immunohistochemistry Detection of Programmed Cell Death Ligand 1 (PD-L1) on Non–Small Cell Lung Carcinoma. Applied immunohistochemistry & molecular morphology. 26(2). 83–93. 105 indexed citations

13.

Parra, Edwin R., Pamela Villalobos, & Jaime Rodriguez‐Canales. (2017). The Multiple Faces of Programmed Cell Death Ligand 1 Expression in Malignant and Nonmalignant Cells. Applied immunohistochemistry & molecular morphology. 27(4). 287–294. 21 indexed citations

14.

Zhou, Xiaorong, Barrett L. Updegraff, Yabin Guo, et al.. (2017). Dissecting the Role of PCDH7, an Oncogenic Cell Surface Receptor, in Non–Small Cell Lung Cancer. Journal of Thoracic Oncology. 12(8). S1542–S1542. 1 indexed citations

15.

Schliekelman, Mark J., Chad J. Creighton, Brandi N. Baird, et al.. (2017). Thy-1+ Cancer-associated Fibroblasts Adversely Impact Lung Cancer Prognosis. Scientific Reports. 7(1). 6478–6478. 40 indexed citations

16.

Zhou, Xiaorong, Barrett L. Updegraff, Yabin Guo, et al.. (2017). Abstract 3328: Protochadherin 7 acts through SET and PP2A to potentiate MAPK signaling by EGFR and KRAS during lung tumorigenesis. Cancer Research. 77(13_Supplement). 3328–3328. 1 indexed citations

17.

Zhou, Xiaorong, Barrett L. Updegraff, Yabin Guo, et al.. (2016). PROTOCADHERIN 7 Acts through SET and PP2A to Potentiate MAPK Signaling by EGFR and KRAS during Lung Tumorigenesis. Cancer Research. 77(1). 187–197. 56 indexed citations

18.

Villalobos, Pamela & Ignacio I. Wistuba. (2016). Lung Cancer Biomarkers. Hematology/Oncology Clinics of North America. 31(1). 13–29. 187 indexed citations

19.

Çeliktaş, Müge, Ichidai Tanaka, S. C. Tripathi, et al.. (2016). Role of CPS1 in Cell Growth, Metabolism, and Prognosis in LKB1-Inactivated Lung Adenocarcinoma. JNCI Journal of the National Cancer Institute. 109(3). djw231–djw231. 82 indexed citations

20.

Peng, David H., Christin Ungewiss, Pan Tong, et al.. (2016). ZEB1 induces LOXL2-mediated collagen stabilization and deposition in the extracellular matrix to drive lung cancer invasion and metastasis. Oncogene. 36(14). 1925–1938. 162 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact